Related Experiment Video
Updated: Jul 14, 2026
18:48
Murine Renal Transplantation Procedure
Published on: July 10, 2009
The UNOS Renal Transplant Registry
1UCLA Immunogenetics Center, Department of Pathology, University of California Los Angeles, Los Angeles, California, USA.
Clinical Transplants
|September 16, 2003
Summary
Kidney transplant survival rates have improved, with living donor transplants showing better outcomes than cadaveric ones. HLA matching remains crucial for long-term graft survival, even with advancements in immunosuppression.
Area of Science:
- Nephrology
- Transplantation Immunology
- Public Health
Background:
- Kidney transplantation is a vital treatment for end-stage renal disease.
- Graft survival rates have historically varied based on donor type and recipient factors.
- Advancements in immunosuppression and donor selection criteria aim to improve outcomes.
Purpose of the Study:
- To analyze trends and outcomes of kidney transplantation using UNOS Renal Transplant Registry data from 1998-2001.
- To evaluate the impact of donor type, donor characteristics, and HLA matching on graft survival.
- To assess changes in kidney transplant practices, including the rise of living donor and expanded criteria donor transplants.
Main Methods:
- Retrospective analysis of 31,720 cadaveric and 14,162 living donor kidney transplants reported to the UNOS Registry (1998-2001).
- Comparison of graft survival rates between different donor types, repeat vs. first transplants, and expanded criteria donors vs. standard donors.
- Evaluation of the impact of HLA-A, -B, and -DR matching on graft survival over time.
- Analysis of trends in living donor transplant types and surgical approaches.
Main Results:
- One-year graft survival: 89% (cadaveric) vs. 95% (living donor). Projected 10-year survival: 51% (cadaveric) vs. 68% (living donor).
- Repeat transplants had lower 3-year survival (73-77%) than first transplants (79%).
- Expanded criteria donor (ECD) kidneys had poorer 3-year survival (68%) and half-life (7.1 years) compared to normal donors (81% and 11.9 years).
- HLA matching at HLA-A, -B, and -DR loci significantly improved projected 10-year graft survival by 16% compared to mismatched grafts.
- Living donor transplants, including HLA-disparate ones, showed high graft survival rates comparable to related donors.
Conclusions:
- Significant improvements in kidney transplant outcomes observed compared to earlier periods.
- Living donor kidney transplantation offers superior graft survival rates.
- HLA matching remains a critical determinant of long-term kidney graft survival.
- Expanded criteria donors and repeat transplants present ongoing challenges for graft longevity.
Related Concept Videos
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...